Egalet Corporation (Nasdaq: EGLT) announced top-line results from a pharmacokinetic study demonstrating bioequivalence (BE) of OXAYDO (oxycodone HCl, USP) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE